These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8677079)

  • 21. Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies.
    Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S55-8. PubMed ID: 2112054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancer.
    Pronzato P; Vigani A; Pensa F; Vanoli M; Tani F; Vaira F
    Am J Clin Oncol; 1997 Oct; 20(5):519-21. PubMed ID: 9345341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gynecologic Oncology Group experience with ifosfamide.
    Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):6-10. PubMed ID: 2159188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot study of daily ifosfamide 1 g/m2 until grade III granulocytopenia as second-line chemotherapy for anthracycline-pretreated advanced soft tissue sarcoma.
    Babović N; Jelić S; Milanović N; Matković S
    Tumori; 1998; 84(6):677-80. PubMed ID: 10080676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I trial of a 24-h continuous infusion of ifosfamide/mesna in acute lymphoblastic leukemia.
    Otero JC; Solidoro A; Casanova L; Vallejos C; Rodriguez W
    J Exp Ther Oncol; 1996 Mar; 1(2):84-7. PubMed ID: 9414391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II evaluation of ifosfamide/mesna in metastatic prostate cancer. A Southwest Oncology Group study.
    Williamson SK; Wolf MK; Eisenberger MA; O'Rourke MA; Brannon W; Crawford ED
    Am J Clin Oncol; 1996 Aug; 19(4):368-70. PubMed ID: 8677906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I study of prolonged ambulatory infusion of Ifosfamide with oral mesna.
    Olver I; Keefe D; Myers M; Caruso D
    Chemotherapy; 2005 May; 51(2-3):142-6. PubMed ID: 15886474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin and ifosfamide-mesna in advanced and recurrent uterine sarcomas.
    Piura B; Rabinovich A
    Eur J Gynaecol Oncol; 2005; 26(3):275-8. PubMed ID: 15991525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ifosfamide in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck: a phase II Hoosier Oncology Group trial.
    Sandler A; Saxman S; Bandealy M; Heilman D; Monaco F; McClean J; Arquette M
    Am J Clin Oncol; 1998 Apr; 21(2):195-7. PubMed ID: 9537211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study.
    Budd GT; Metch B; Weiss SA; Weick JK; Fabian C; Stephens RL; Balcerzak SP
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S213-6. PubMed ID: 8453701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ifosfamide bolus followed by five days continuous infusion in extensively pretreated patients with advanced breast cancer: a phase II study.
    Bisagni G; Boni C; Manenti AL; Moretti G; Rondini E; Sassi M; Zadro A; Savoldi L
    Tumori; 1998; 84(6):659-61. PubMed ID: 10080671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients.
    Lee SH; Chang MH; Baek KK; Han B; Lim T; Lee J; Park JO
    Oncology; 2011; 80(3-4):257-61. PubMed ID: 21734417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
    Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM;
    Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.
    Sutton G; Blessing JA; Malfetano JH
    Gynecol Oncol; 1996 Aug; 62(2):226-9. PubMed ID: 8751554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study.
    Bernstein ML; Whitehead VM; Devine S; Grier H; Kung F; Krischer J; Dreyer Z; Bell B; Land V; Buchanan GR
    Cancer; 1993 Sep; 72(5):1790-4. PubMed ID: 8348510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of recurrent high-grade endometrial stromal sarcoma controlled by a combination of Ifosfamide, adriamycin, and cisplatin].
    Ushijima M; Yamakawa Y; Sakabe E; Waki H; Katou K
    Gan To Kagaku Ryoho; 2010 Oct; 37(10):2003-5. PubMed ID: 20948274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of stage IV "high-grade" endometrial stromal sarcoma with ifosfamide, adriamycin, and cisplatin.
    Yamawaki T; Shimizu Y; Hasumi K
    Gynecol Oncol; 1997 Feb; 64(2):265-9. PubMed ID: 9038274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomas.
    Güllü I; Yalçin S; Tekuzman G; Barişta I; Alkiş N; Celik I; Zengin N; Güler N; Kars A; Baltali E
    Cancer Invest; 1996; 14(3):239-42. PubMed ID: 8630686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.
    Miser JS; Kinsella TJ; Triche TJ; Tsokos M; Jarosinski P; Forquer R; Wesley R; Magrath I
    J Clin Oncol; 1987 Aug; 5(8):1191-8. PubMed ID: 3114435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients.
    van Oosterom AT; Mouridsen HT; Nielsen OS; Dombernowsky P; Krzemieniecki K; Judson I; Svancarova L; Spooner D; Hermans C; Van Glabbeke M; Verweij J;
    Eur J Cancer; 2002 Dec; 38(18):2397-406. PubMed ID: 12460784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.